UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TWI PHARMACEUTICALS, INC.,
`Petitioner,
`
`MERCK SERONOSA,
`Patent Owner.
`
`
`Case IPR2023-00049
`U.S. Patent No. 7,713,947
`
`
`DECLARATION OF VINITA FERRERA
`
`IN SUPPORT OF MOTION FOR ADMISSION PRO HAC VICE
`
`Merck 2002
`TWi1v Merck
`
`IPR2023-00049
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TWI PHARMACEUTICALS, INC.,
`Petitioner,
`
`MERCK SERONOSA,
`Patent Owner.
`
`
`Case IPR2023-00049
`U.S. Patent No. 7,713,947
`
`
`DECLARATION OF VINITA FERRERA
`
`IN SUPPORT OF MOTION FOR ADMISSION PRO HAC VICE
`
`Merck 2002
`TWi1v Merck
`
`IPR2023-00049
`
`
`
`Case No. IPR2023-00049
`Declaration of Vinita Ferrera in Support of
`Motion for Admission Pro Hac Vice
`
`I, Vinita Ferrera, declare as follows:
`
`1.
`
`I was admitted to the Massachusetts Bar in February 1996 and the
`
`New York Bar in April 1996.
`
`I have been practicing law for over 27 years.
`
`Mypractice has focused on patentlitigation disputes in a variety of
`
`jurisdictions, with a particular emphasis on patentlitigation in the life sciences
`
`fields.
`
`2.
`
`I have been counsel of record in over 40 patent litigations and
`
`participated in all aspects of such litigation, including trials and appeals.
`
`3.
`
`I am a memberin good standing of the Bars of Massachusetts and
`
`New York and am admitted to practice before the U.S. District Court for the
`
`District of Massachusetts and the U.S. District Court for the District of
`
`Colorado.
`
`I am also admitted to practice before the U.S. Court of Appeals for
`
`the Federal Circuit, the First Circuit, and the Second Circuit.
`
`4.
`
`MyMassachusetts Bar membership numberis 631190. My New
`
`York Bar membership numberis 2750727.
`
`5.
`
`I have never been suspendedordisbarred from practice before any
`
`court or administrative body.
`
`6.
`
`I have never had a court or administrative body deny my
`
`application for admission to practice.
`
`
`
`Case No. IPR2023-00049
`Declaration of Vinita Ferrera in Support of
`Motion for Admission Pro Hac Vice
`
`7.
`
`I have neverhad any sanctions or contemptcitations imposed by
`
`any court or administrative body.
`
`8.
`
`I have read and will comply with the Patent Office Trial Practice
`
`Guide and the Board’s Rules for Practice for Trials, as set forth in 37 C.F.R. Part
`
`42.
`
`9.
`
`I agree to be subject to the United States Patent and Trademark
`
`Office Rules of Professional Conductset forth in 37 C.F.R. §§ 11.101 et seg.
`
`and disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`10.—_In the past three years, I have appeared pro hacvice before the
`
`United States Patent and Trademark Office in the following proceedings: Hopewell
`
`Pharma Ventures, Inc., v. Merck Serono SA, including Case Nos. IPR2023-00480
`
`and IPR2023-00481.
`
`11.
`
`Tam intimately familiar with the subject matter at issue in this
`
`proceeding. I have reviewedthe papers and exhibits filed in this proceeding. I
`
`also participated in drafting papers filed thus far in this proceeding. In addition to
`
`this proceeding,I participated in reviewing anddrafting papers in the related inter
`
`partes review matters challenging U.S. Patent No. 7,713,947 (the “’947 patent’)
`
`and U.S. Patent No. 8,377,903 (the “’903 patent’), which werefiled as Hopewell
`
`Pharma Ventures, Inc., v. Merck Serono SA, IPR2023-00480 and Hopewell
`
`
`
`Case No. IPR2023-00049
`Declaration of Vinita Ferrera in Support of
`Motion for Admission Pro Hac Vice
`
`Pharma Ventures, Inc., v. Merck Serono SA, IPR2023-00481, respectively.
`
`Moreover, I am currently representing Merck KGaA, Merck Serono SA, and Ares
`
`Trading SA (collectively, “Merck’’) in the following parallel district court
`
`litigations, in which the 947 patent is a patent-in-suit: Merck KGaA, Merck Serono
`
`SA, and Ares Trading SA v. Accord Healthcare, Inc., No. 1:22-cv-00974-GBW (D.
`
`Del.) and Merck KGaA, Merck Serono SA, and Ares Trading SA v. Hopewell
`
`PharmaVentures, Inc., et al., No. 1:22-cv-01365-GBW (consolidated)! (D. Del.).
`
`12.
`
`I am also familiar with pharmaceuticals, methods of treatment, and
`
`small molecule therapeutics. I have represented a numberoflife sciences,
`
`pharmaceutical, biotechnology, and diagnostics companies, including Gilead
`
`' The following cases have been consolidated as Merck Serono SA, and Ares
`
`Trading SA v. Hopewell Pharma Ventures, Inc., et al., No. 1:22-cv-01365-GBW
`
`(D. Del.): Merck KGaA, Merck Serono SA, and Ares Trading SA v. Hopewell
`
`Pharma Ventures, Inc., No. 1:22-cv-01365-GBW (D. Del.); Merck KGaA, Merck
`
`Serono SA, and Ares Trading SA v. Aurobindo Pharma USA, Inc. and Aurobindo
`
`Pharma Limited, No. 1:23-cv-00039-GBW (D. Del.); and Merck KGaA, Merck
`
`Serono SA, and Ares Trading SA v. Apotex Inc. and Apotex Corp., No. 1:23-cv-
`
`00655-GBW(D. Del.).
`
`
`
`Case No. IPR2023-00049
`Declaration of Vinita Ferrera in Support of
`Motion for Admission Pro Hac Vice
`
`Sciences, Inc.; AbbVie, Inc.; GlaxoSmithKline; Novartis Corporation; Precision
`
`Biosciences, Inc.; Palomar Medical Technologies, Inc.; Proctor & Gamble Co.;
`
`Millennium Pharmaceuticals, Inc.; Shionogi, Inc.; and other companies in
`
`confidential representations in manypatentlitigation matters, including before
`
`federal district courts.
`
`13.
`
`[hereby declare that all statements made herein ofmy own
`
`knowledgeare true and that all statements made on information and beliefare
`
`believed to be true; and further that these statements are made with the knowledge
`
`that willful false statements andthe like are punishable by fine, imprisonment, or
`
`both under Section 1001 of Title 18 ofthe United States Code.
`
`Dated:
`
`January 29, 2024
`
`Respectfully Submitted,
`Vind Fore
`
`
`Vinita Ferrera
`Wilmer Cutler Pickering
`Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`(617) 526-6000
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
